[Federal Register Volume 88, Number 231 (Monday, December 4, 2023)]
[Notices]
[Pages 84161-84162]
[FR Doc No: 2023-26563]

-----------------------------------------------------------------------

DEPARTMENT OF HOMELAND SECURITY

Federal Emergency Management Agency

[Docket ID: FEMA- 2023-0014; OMB No. 1660-NW164]

Agency Information Collection Activities: Proposed Collection;
Comment Request; an Investigation of the Effect of Disaster Response
and Recovery on Perceived Stress and Emotional Trauma

AGENCY: Federal Emergency Management Agency, Department of Homeland
Security.

ACTION: 60-Day notice of new collection and request for comments.

-----------------------------------------------------------------------

SUMMARY: The Federal Emergency Management Agency (FEMA), as part of its
continuing effort to reduce paperwork and respondent burden, invites
the general public to take this opportunity to comment on an
Investigation of the Effect of Disaster Response and Recovery on
Perceived Stress and Emotional Trauma. In accordance with the Paperwork
Reduction Act of 1995, this notice seeks comments concerning the effect
of disasters on the mental health of emergency managers at local,
State, and Federal levels.

DATES: Comments must be submitted on or before February 2, 2024.

ADDRESSES: To avoid duplicate submissions to the docket, please submit
comments at www.regulations.gov under Docket ID FEMA-2023-0014. Follow
the instructions for submitting comments.
    All submissions received must include the agency name and Docket
ID. Regardless of the method used for submitting comments or material,
all submissions will be posted, without change, to the Federal
eRulemaking Portal at http://www.regulations.gov, and will include any
personal information you provide. Therefore, submitting this
information makes it public. You may wish to read the Privacy and
Security Notice that is available via a link on the homepage of
www.regulations.gov.

FOR FURTHER INFORMATION CONTACT: Megan Corley, Supervisory
Psychologist, FEMA Mental Health, at [email protected] or
(202) 880-7506. You may contact the Information Management Division for
copies of the proposed collection of information at email address:
[email protected].

SUPPLEMENTARY INFORMATION: A study to investigate the effect of
disaster response and recovery on emergency managers was requested by
Congress in the Consolidated Appropriations Act, 2021 (Pub. L. 116-
260). 29 CFR part 1960, entitled ``Basic Program Elements for Federal
Employee Occupational Safety and Health Programs and Related Matters'',
contains special provisions to assure safe and healthful working
conditions for Federal employees; requiring the head of each Federal
Agency to maintain an effective and comprehensive occupational safety
and health program consistent with section 6 of the Occupational Safety
and Health Administration Act of 1970 (Pub. L. 91-596) (OSHA Act).
Furthermore, 5 U.S.C. 7902 requires the head of each agency to develop
and support organized safety promotion to reduce accidents and injuries
to its employees, encourage safe practices, and eliminate hazards and
risks. Under 5 U.S.C. 7902(e), Agencies must also keep a record of
injuries and accidents.
    This program was established to improve the mental health of
FEMA's, as well as State and local, emergency managers in response to
the effects of stress caused by disasters. This data collection is
needed to comply with the OSHA Act, 5 U.S.C. 7902 requiring the
monitoring, reporting, and mitigation of workplace injuries, and with
the request from Congress to undertake this survey.

Collection of Information

    Title: An Investigation of the Effect of Disaster Response and
Recovery on Perceived Stress and Emotional Trauma.
    Type of Information Collection: New information collection.
    OMB Number: 1660-NW164.
    FEMA Forms: FEMA Form FF-119-FY-23-100, FEMA Congressional Mental
Health Emergency Manager Wellness Study Survey.
    Abstract: This information collection supports a study to
investigate the effect of disaster response and recovery on emergency
managers that was requested by Congress in 2022. This is a voluntary
survey that will be collected electronically with approximately 38
questions pertaining to the individuals' experience and demographics,
as well as their perceptions of emotional trauma and stress symptoms
while supporting a disaster response or recovery. Prior to seeing these
questions, participants will see an informed consent screen that
outlines the nature of the study, risks, benefits, and Institutional
Review Board (IRB) information. Participants may choose to end the
survey at any time without questions being asked. Participants are
given mental health resources to support them in the event of emotional
triggering.
    Affected Public: State, local, and Tribal governments.
    Estimated Number of Respondents: 378.
    Estimated Number of Responses: 378.
    Estimated Total Annual Burden Hours: 189.
    Estimated Total Annual Respondent Cost: $11,712.
    Estimated Respondents' Operation and Maintenance Costs: $0.
    Estimated Respondents' Capital and Start-Up Costs: $0.
    Estimated Total Annual Cost to the Federal Government: $306,752.

Comments

    Comments may be submitted as indicated in the ADDRESSES caption
above. Comments are solicited to (a) evaluate whether the proposed data
collection is necessary for the proper performance of the agency,
including whether the information shall have practical utility; (b)
evaluate the accuracy of the agency's estimate of the burden of the
proposed collection of information, including the validity of the
methodology and assumptions used; (c) enhance the quality, utility, and
clarity of the information to be collected; and (d) minimize the burden
of the collection of information on those

who are to respond, including through the use of appropriate automated,
electronic, mechanical, or other technological collection techniques or
other forms of information technology, e.g., permitting electronic
submission of responses.

Millicent Brown Wilson,
Records Management Branch Chief, Office of the Chief Administrative
Officer, Mission Support, Federal Emergency Management Agency,
Department of Homeland Security.
[FR Doc. 2023-26563 Filed 12-1-23; 8:45 am]
BILLING CODE 9111-19-P


Models Used in F019 Risk Analysis

As of Jan. 16, 2007, the Uniform Resource Locators (“web addresses”)
to obtain the fate and transport model software used in the proposal to
amend the F019 listing to exempt wastewater treatment sludges from zinc
phosphating, when zinc phosphating is used in the motor vehicle
manufacturing process, were:

DRASv2  -    HYPERLINK
"http://www.epa.gov/region6/6pd/rcra_c/pd-o/dras/dras.htm"
http://www.epa.gov/region6/6pd/rcra_c/pd-o/dras/dras.htm

IWEM –    HYPERLINK
"http://www.epa.gov/epaoswer/non-hw/industd/iwem.htm"
http://www.epa.gov/epaoswer/non-hw/industd/iwem.htm

EPACMTP  -    HYPERLINK
"http://www.epa.gov/epaoswer/non-hw/industd/tools/cmtp/epacmtp.htm"
http://www.epa.gov/epaoswer/non-hw/industd/tools/cmtp/epacmtp.htm


[Federal Register Volume 80, Number 155 (Wednesday, August 12, 2015)]
[Notices]
[Pages 48306-48315]
[FR Doc No: 2015-19828]

=======================================================================
-----------------------------------------------------------------------

ENVIRONMENTAL PROTECTION AGENCY

[EPA-HQ-OPP-2015-0423; FRL-9929-66]

Nominations to the FIFRA Scientific Advisory Panel; Request for
Comments

AGENCY: Environmental Protection Agency (EPA).

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: This notice provides the names, addresses, professional
affiliations, and selected biographical data of persons recently
nominated to serve on the Scientific Advisory Panel (SAP) established
under section 25(d) of the Federal Insecticide, Fungicide, and
Rodenticide Act (FIFRA). The Panel was created on November 28, 1975,
and made a statutory Panel by amendment to FIFRA, dated October 25,
1988. The Agency, at this time, anticipates selecting two new members
to serve on the panel as a result of membership terms that will expire
in 2015. Public comments on the current nominations are invited, as
these comments will be used to assist the Agency in selecting the new
chartered Panel members.

DATES: Comments, identified by docket ID number EPA-HQ-OPP-2015-0423,
must be received on or before August 27, 2015.

ADDRESSES: Submit your comments, identified by docket identification
(ID) number EPA-HQ-OPP-2015-0423, by one of the following methods:
     Federal eRulemaking Portal: http://www.regulations.gov.
Follow the online instructions for submitting comments. Do not submit
electronically any information you consider to be Confidential Business
Information (CBI) or other information whose disclosure is restricted
by statute.
     Mail: OPP Docket, Environmental Protection Agency Docket
Center (EPA/DC), (28221T), 1200 Pennsylvania Ave. NW., Washington, DC
20460-0001.

     Hand Delivery: To make special arrangements for hand
delivery or delivery of boxed information, please follow the
instructions at http://www.epa.gov/dockets/contacts.html.

FOR FURTHER INFORMATION CONTACT: Steven M. Knott, DFO, Office of
Science Coordination and Policy (7201M), Environmental Protection
Agency, 1200 Pennsylvania Ave. NW., Washington, DC 20460-0001;
telephone number:<PHONE_NUMBER>; fax number:<PHONE_NUMBER>; email
address<EMAIL_ADDRESS>
SUPPLEMENTARY INFORMATION:

 I. General Information

 A. Does this action apply to me?

    This action is directed to the public in general. This action may,
however, be of interest to persons who are or may be required to
conduct testing of chemical substances under the Federal Food, Drug,
and Cosmetic Act (FFDCA) and FIFRA. Since other entities may also be
interested, the Agency has not attempted to describe all the specific
entities that may be affected by this action. If you have any questions
regarding the applicability of this action to a particular entity,
consult the DFO listed under FOR FURTHER INFORMATION CONTACT.

B. What should I consider as I prepare my comments for EPA?

    When submitting comments, remember to:
    1. Identify the document by docket ID number and other identifying
information (subject heading, Federal Register date and page number).
    2. Follow directions. The Agency may ask you to respond to specific
questions or organize comments by referencing a Code of Federal
Regulations (CFR) part or section number.
    3. Explain why you agree or disagree; suggest alternatives and
substitute language for your requested changes.
    4. Describe any assumptions and provide any technical information
and/or data that you used.
    5. If you estimate potential costs or burdens, explain how you
arrived at your estimate in sufficient detail to allow for it to be
reproduced.
    6. Provide specific examples to illustrate your concerns and
suggest alternatives.
    7. Explain your views as clearly as possible, avoiding the use of
profanity or personal threats.
    8. Make sure to submit your comments by the comment period deadline
identified.

II. Background

    The FIFRA SAP serves as the primary scientific peer review
mechanism of EPA's Office of Chemical Safety and Pollution Prevention
(OCSPP) and is structured to provide scientific advice, information and
recommendations to the EPA Administrator on pesticides and pesticide-
related issues as to the impact of regulatory actions on health and the
environment. Established in 1975 under FIFRA, the FIFRA SAP is a
Federal advisory committee that operates in accordance with
requirements of the Federal Advisory Committee Act (FACA). The FIFRA
SAP is composed of a permanent panel consisting of seven members who
are appointed by the EPA Administrator from nominees provided by the
National Institutes of Health (NIH) and the National Science Foundation
(NSF). FIFRA established a Science Review Board consisting of at least
60 scientists who are available to the SAP on an ad hoc basis to assist
in reviews conducted by the FIFRA SAP. As a peer review mechanism, the
FIFRA SAP provides comments, evaluations and recommendations to improve
the effectiveness and quality of analyses made by Agency scientists.
Members of the FIFRA SAP are scientists who have sufficient
professional qualifications, including training and experience, to
provide expert advice and recommendations to the Agency.
    In accordance with the statute, the SAP is composed of a permanent
panel of seven members, selected and appointed by the Deputy
Administrator of EPA, as designated by the Administrator from nominees
submitted by both the NSF and the NIH. The Agency, at this time,
anticipates selecting two new members to serve on the panel as a result
of membership terms that will expire this year. The Agency requested
nominations of experts to be selected from the fields of human
toxicology, environmental toxicology, pathology, risk assessment and/or
environmental biology with demonstrated experience and expertise in all
phases of the risk assessment process including: Planning, scoping, and
problem formulation; analysis; and interpretation and risk
characterization (including the interpretation and communication of
uncertainty). Nominees should be well published and current in their
field of expertise. The statute further stipulates that we publish the
name, address and professional affiliation in the Federal Register.

III. Charter

    A Charter for the FIFRA Scientific Advisory Panel dated October 17,
2014 was issued in accordance with the requirements of the Federal
Advisory Committee Act, Public Law 92-463, 86 Stat. 770 (5 U.S.C. App.
I).

A. Qualifications of Members

    Members are scientists who have sufficient professional
qualifications, including training and experience, to provide expert
comments on the impact of pesticides on health and the environment. No
persons shall be ineligible to serve on the Panel by reason of their
membership on any other advisory committee to a Federal department or
agency or their employment by a Federal department or agency (except
the EPA). The Deputy Administrator appoints individuals to serve on the
Panel for staggered terms of 3 years. Panel members are subject to the
provisions of 40 CFR part 3, subpart F, Standards of Conduct for
Special Government Employees, which include rules regarding conflicts
of interest. Each nominee selected by the Deputy Administrator, before
being formally appointed, is required to submit a confidential
statement of employment and financial interests, which shall fully
disclose, among other financial interests, the nominee's sources of
research support, if any.
    In accordance with section 25(d)(1) of FIFRA, the Deputy
Administrator shall require all nominees to the Panel to furnish
information concerning their professional qualifications, educational
background, employment history, and scientific publications.

B. Applicability of Existing Regulations

    With respect to the requirements of section 25(d) of FIFRA that the
Administrator promulgate regulations regarding conflicts of interest,
the Charter provides that EPA's existing regulations applicable to
Special Government Employees, which include advisory committee members,
will apply to the members of the Scientific Advisory Panel. These
regulations appear in 40 CFR part 3, subpart F. In addition, the
Charter provides for open meetings with opportunities for public
participation.

C. Process of Obtaining Nominees

    In accordance with the provisions of section 25(d) of FIFRA, EPA,
on April 21, 2015, requested that the NIH and the NSF nominate
scientists to fill vacancies occurring on the Panel. The Agency
requested nominations of experts in the fields of human toxicology,
environmental toxicology, pathology,

risk assessment, and/or environmental biology with demonstrated
experience and expertise in all phases of the risk assessment process
including: Planning, scoping, and problem formulation; analysis; and
interpretation and risk characterization (including the interpretation
and communication of uncertainty). NIH and NSF responded by letter,
providing the Agency with a total of 34 nominees. Copies of these
letters, with the listed nominees, are available in the public docket
referenced in unit I.B.1. of this notice. Of the 34 nominees, 18 are
interested and available to actively participate in SAP meetings (see
Section IV. Nominees). One nominee is currently serving as member of
the FIFRA SAP, and is not listed. In addition to the current nominees
interested, at EPA's discretion, nominees who were interested and
available during the previous nomination process in the January 24,
2014 Federal Register (79 FR 4158) (FRL-9904-66), may also be
considered. Of the current 34 nominations, the following 15 individuals
are not available:

    1. Asa Bradman, Ph.D., University of CA, Berkeley, CA.
    2. Mark G. Evans, DVM, Ph.D., ACVP, Pfizer Global Research and
Development Drug Safety Research and Development, San Diego, CA.
    3. John Groopman, Ph.D., Johns Hopkins University, Baltimore,
MD.
    4. Stephen S. Hecht, Ph.D., University of Minnesota,
Minneapolis, MN.
    5. Marie Lyn Miranda, Ph.D., Rice University, Houston, TX.
    6. Frederica P. Perera, Ph.D., MPH, Columbia University, New
York, NY.
    7. Irva Hertz-Picciotto, Ph.D., University of California, Davis,
CA.
    8. Thomas A.E. Platts-Mills, M.D., University of Virginia,
Charlottesville, VA.
    9. Michael Roe, Ph.D., North Carolina State University, Raleigh,
NC.
    10. Ana Diez Roux, M.D, Ph.D., MPH, Drexel University,
Philadelphia, PA.
    11. Jonathan M. Samet, MD, University of Southern California,
Los Angeles, CA.
    12. David Siegel, MD, National Institute of Health, Rockville,
MD.
    13. Allan H. Smith, MD, Ph.D., University of California,
Berkeley, CA.
    14. Frank Speizer, SCD, MD, Harvard Medical School, Boston, MA.
    15. Robert Williams, MD, University of New Mexico Health
Sciences Center, Albuquerque, NM.

IV. Nominees

    Following are the names, addresses, professional affiliations, and
selected biographical data of current nominees being considered for
membership on the FIFRA SAP. The Agency anticipates selecting two
individuals to fill vacancies occurring in 2015.

1. Nicole L. Achee, Ph.D.

    i. Expertise: Epidemiology control of arthropod-borne diseases
including evaluation of vector ecology, habitat management, and adult
control strategies, disease risk modeling using GIS and remote sensing
technologies, and evaluation of chemical actions against mosquito
vectors under both laboratory and field conditions.
    ii. Education: Ph.D. Medical Entomology, Uniformed Services
University of the Health Sciences; MSc, Zoology, Texas A&M University;
BS, Biology, St. Louis University.
    iii. Professional Experience: Dr. Achee is a Medical Entomologist
(Research Associate Professor) within the Department of Biological
Sciences and holds a joint Associate Professor appointment in the Eck
Institute for Global Health at the University of Notre Dame. She joined
the University of Notre Dame faculty in 2013, following a 2-year
position as Assistant Professor at the Uniformed Services University of
the Health Sciences in Bethesda, MD. She has a combined 15 years of
experience in vector behavior research related to the epidemiology and
control of arthropod-borne diseases, including evaluation of vector
ecology, habitat management and adult control strategies, disease risk
modeling using GIS and remote sensing technologies, and evaluation of
chemical actions against mosquito vectors under both laboratory and
field conditions. She has worked in the international settings of
Belize, Mexico, Peru, Suriname, Indonesia, Nepal, South Korea,
Thailand, and Tanzania. Dr. Achee was the principal investigator of a
research program funded by the Bill & Melinda Gates Foundation focused
on the development of spatial repellents in combination push-pull
systems to reduce human-vector contact for dengue prevention. She is a
Working Group member of the World Health Organization (WHO) Pesticide
Evaluation Scheme (WHOPES), the Chair of the American Committee of
Medical Entomology (ACME) of the American Society of Tropical Medicine
and Hygiene (ASTMH), a representative of the WHO Global Collaboration
for the Development of Pesticides for Public Health partnership
(GCDPP), Vector Control Working Group member of Roll Back Malaria and
served as the lead scientist for the recent publication of the WHO
Guidelines for Efficacy Testing of Spatial Repellents. She is currently
the lead Principal Investigator of a multicenter intervention trial
dedicated to generating evidence of the protective efficacy of spatial
repellents for prevention of malaria and dengue human infections for
use towards full WHO recommendations. Her latest efforts have been
dedicated to co-Directing the Belize Vector and Ecology Center (BVEC)
in Orange Walk Town, Belize to serve as a regional platform of
excellence for research and education in arthropod-borne diseases.

2. George B. Corcoran, Ph.D., ATS

    i. Expertise: Pharmacological and toxicological adverse cellular
outcomes, and factors that govern drug and chemical injuries including
drug metabolism and nutrition.
    ii: Education: Ph.D., Pharmacology, Department of Pharmacology,
School of Medicine, George Washington University; MS, Chemistry,
Bucknell University; BA, Chemistry, Ithaca College.
    iii. Professional Experience: Dr. Corcoran is Professor and
Chairman of the Department of Pharmaceutical Sciences, College of
Pharmacy & Health Sciences, Wayne State University, and Adjunct
Professor of Pediatrics, Wayne State University School of Medicine. Dr.
Corcoran earned his BA in Chemistry (Ithaca College `70), MS in
Chemistry (Bucknell University `73), and Ph.D. in Pharmacology/
Toxicology (George Washington University `80), before completing
Postdoctoral Fellow training in Toxicology (Baylor College of Medicine
and Methodist Hospital `81). Prior to his appointment at Wayne State,
Dr. Corcoran served as Assistant Professor of Pharmaceutics at the
State University of New York at Buffalo, followed by Associate
Professor and later Professor, and Director of the Toxicology Graduate
Program at the University of New Mexico. Dr. Corcoran has published
over 200 original research papers, abstracts and other reports, and has
received nearly $6 million in grants and contracts as Principal
Investigator, Co-Principal Investigator, and Co-Investigator. He has
chaired grant review panels for the NIH, the National Academies, and
the Howard Hughes Medical Institute, and has refereed papers for more
than 50 national and international scientific journals. He has
contributed to the training of over 150 MS and Ph.D. graduates, 3200
pharmacists, and hundreds of undergraduate research students. His
research interests are multidisciplinary and translational. They focus
on cellular injury and cell death, and factors that govern drug and
chemical injuries, including drug metabolism and nutrition. Approaches
to translate basic discoveries to improve human health involve
retrospective and prospective clinical investigation of human

volunteers and patients, integrated in vivo models, cellular and
molecular biology, pharmacokinetics, and synthetic chemistry. Specific
areas of investigation include cell death by necrosis and apoptosis,
the role of DNA damage in acute cell death, drug and chemical injury to
the liver, nutrition and particularly obesity as overlooked factors in
drug and chemical injury, drug biotransformation including by CYPs, and
toxicity of drugs such as acetaminophen (paracetamol). Dr. Corcoran is
a Fellow of the Academy of Toxicological Sciences, the top US
credentialing organization for toxicologists. He was elected to its
Executive Board and appointed to the National Toxicology Program Board
of Scientific Counselors in 2012. He has been a Delegate to the
International Congress of Toxicology and member of the International
Union of Toxicology Developing Countries Committee. He is a former
Member of the Science Advisory Board of the US Environmental Protection
Agency, is former Chair of the Executive Board of the Council of
Scientific Society Presidents, and is a past member of the
Intergovernmental Scientific Advisory Committee on Alternative
Toxicological Methods. He has contributed to the scientific direction
of the American Society for Pharmacology and Experimental Therapeutics
as a member of its Scientific Council, and served on the Research and
Graduate Affairs Committee of the American Association of Colleges of
Pharmacy. Dr. Corcoran is sought as an expert in toxic tort, product
liability and other legal matters. At the University of New Mexico, Dr.
Corcoran advised Health Sciences Vice President Jane Henney (FDA
Commissioner 1998-2000) as a member of her Health Sciences Leadership
Council. He is Past President of the Society of Toxicology, the largest
toxicology organization in the world with over 7,000 members from
academia, industry, government, medicine, law and other fields
practicing in the USA and over 50 foreign countries. He has contributed
to Society positions having national and international impact, from the
best science for evidence-based safety legislation, to organization
ethics and governance. He serves as Associate Editor of Toxicology and
Applied Pharmacology [2002-date], Editor of the Journal of
Pharmaceutical Sciences and Pharmacology [2014-date] and Editor of the
MO Online Journal of Toxicology [2014-date]. He has been an Editorial
Board Member of the international journals Pharmacology and Toxicology,
Basic and Clinical Pharmacology and Toxicology, Toxicology Letters, and
the Journal of Toxicology and Environmental Health. During his service
on the National Institutes of Health Alcohol-Toxicology 1 Study
Section, he evaluated over 1,000 NIH grant applications.

3. Deborah A. Cory-Slechta, Ph.D.

    i. Expertise: Relationship between brain neurotransmitter systems
and neurodevelopment associated with alteration by exposures to
environmental toxicants.
    ii: Education: Ph.D., Experimental Psychology, University of
Minnesota; MA, Experimental Psychology, Western Michigan University;
BS, Psychology, Western Michigan University.
    iii. Professional Experience: Dr. Deborah Cory-Slechta is a
Professor in the Department of Environmental Medicine, Pediatrics and
Public Health Sciences at the University of Rochester School of
Medicine and Dentistry. Dr. Deborah Cory-Slechta became Chair of its
Department of Environmental Medicine and Director of the NIEHS
Environmental Health Sciences Center in 1998, and served as Dean for
Research from 2000-2002. She then became Director of the Environmental
and Occupational Health Sciences Institute (EOHSI) and Chair of the
Department of Environmental and Community Medicine at the UMDNJ-Robert
Wood Johnson Medical School from 2003-2007, before returning to URMC as
Professor in Environmental Medicine, Pediatrics and Public Health
Sciences. Dr. Cory-Slechta has served on national review and advisory
panels of the National Institutes of Health, the National Institute of
Environmental Health Sciences, the Food and Drug Administration, the
National Center for Toxicological Research, the Environmental
Protection Agency, the National Academy of Sciences, the Institute of
Medicine, and the Agency for Toxic Substances and Disease Registry,
Centers for Disease Control. In addition, Dr. Cory-Slechta has served
on the editorial boards of the journals Neurotoxicology, Toxicology,
Toxicological Sciences, Fundamental and Applied Toxicology,
Neurotoxicology and Teratology, and American Journal of Mental
Retardation. She has held the elected positions of President of the
Neurotoxicology Specialty Section of the Society of Toxicology,
President of the Behavioral Toxicology Society, and been named a Fellow
of the American Psychological Association. Her research has focused
largely on the relationships between brain neurotransmitter systems and
neurodevelopment, and how such relationships are altered by exposures
to environmental toxicants, including the role played by environmental
neurotoxicant exposures in developmental disabilities and
neurodegenerative diseases. This work has included the effects of
developmental exposures to metals, pesticides, and air pollutants as
well as combined exposures to metals and stress in experimental animal
models as well as in human cohort studies. These research efforts have
resulted in over 155 papers and book chapters to date.

4. Victor G. De Gruttola, ScD

    i. Expertise: Development of innovative study designs and
analytical methods for evaluation of new therapies for HIV-related
disease.
    ii. Education: ScD, Biostatistics, Harvard School of Public Health;
SM, Bioengineering, Harvard University; SM, Epidemiology, Harvard
School of Public Health; BS, Physics, Brown University.
    iii. Professional Experience: Dr. De Gruttola received his ScD in
1986 from the Biostatistics Department at HSPH--the department for
which he served as Chair from 2009-2014. His research focuses on
development of statistical methods required for appropriate public
health response to the AIDS epidemic both within the US and
internationally. The aspects of the epidemic on which he has worked
include transmission of, and natural history of infection with, the
Human Immunodeficiency Virus (HIV), as well as research on
antiretroviral treatments, including the development and consequences
of resistance to treatments. The broad goals of his research include
developing treatment strategies that provide durable virologic
suppression while preserving treatment options after failure, and
evaluating the community-level impact of packages of prevention
interventions, including antiviral treatment. He served as the Director
of the Statistics and Data Analysis Center of the Adult Project of the
AIDS Clinical Trials Group from 1996 to 2003--the period in which
highly active antiretroviral treatment was developed, and he was
instrumental in designing and analyzing studies of the best means of
providing such therapy. He also served from 2011-2015, as co-PI (with
PI Max Essex) on a community-randomized study of a combination HIV
prevention strategy in Botswana.

5. David C. Dorman, DVM, Ph.D., DABVT, DABT, ATS

    i. Expertise: Neurotoxicology, and risk assessment.

    ii: Education: Ph.D., Veterinary Biosciences/Toxicology, University
of Illinois; DVM Colorado State University; B.A. Chemistry, University
of San Diego.
    iii. Professional Experience: Dr. Dorman is a professor of
toxicology in the Department of Molecular Biosciences in the College of
Veterinary Medicine at North Carolina State University. Dr. Dorman
received his undergraduate training in chemistry from the University of
San Diego, his DVM from Colorado State University, and he completed a
combined Ph.D. and residency program in toxicology at the University of
Illinois, Urbana-Champaign. He is a diplomat of the American Board of
Veterinary Toxicology and the American Board of Toxicology. Dr. Dorman
has chaired or served on numerous NRC committees. His recent NRC
chairmanships include the Committee on Predictive-Toxicology Approaches
for Military Assessments of Acute Exposures and the Committee on Design
and Evaluation of Safer Chemical Substitutions--A Framework to Inform
Government and Industry Decisions. He has been recently named as chair
of the NRC's Committee on Toxicology and the Committee on Unraveling
Low Dose Toxicity: Case Studies of Systematic Review of Evidence. He
has served on other advisory boards for the US Navy, NASA, and USDA,
and is currently a member of the National Toxicology Program's Board of
Scientific Counselors. He is an elected fellow of both the Academy of
Toxicological Sciences and the American Association for the Advancement
of Sciences. The primary objective of his research is to provide a
refined understanding of chemically induced neurotoxicity in laboratory
animals that will lead to improved assessment of potential
neurotoxicity in humans. Dr. Dorman's other research interests include
clinical veterinary toxicology, nasal toxicology, pharmacokinetics, and
cognition and olfaction in animals. He has over 145 peer-reviewed
research publications including work with pesticides, metals, hydrogen
sulfide, and a variety of industrial chemicals.

6. Valery E. Forbes, Ph.D.

    i. Expertise: Population ecology and modeling, fate and effects of
toxic chemicals in sediments, and ecological risk assessment.
    ii. Education: Ph.D., Coastal Oceanography, State University of New
York; MSc Marine Environmental Science, State University of New York;
BA Biology; BA Geology, State University of New York.
    iii. Professional Experience: Dr. Valery E. Forbes is Dean of the
College of Biological Sciences at University of Minnesota. Dr. Forbes
was Director of the School of Biological Sciences at the University of
Nebraska-Lincoln from 2011-2015. From 1989-2010, she lived and worked
in Denmark, most recently as the Founding Chair of the Department of
Environmental, Social and Spatial Change and Professor of Aquatic
Ecology and Ecotoxicology at Roskilde University. Dr. Forbes received
her Bachelor's Degree (Biology & Geology) from the State University of
New York at Binghamton in 1983, a MSc (Marine Environmental Science)
from SUNY-Stony Brook in 1984, and a Ph.D. (Coastal Oceanography), also
from SUNY- Stony Brook in 1988. Specific research topics include
population ecology and modeling, fate and effects of toxic chemicals in
sediments, and ecological risk assessment. Dr. Forbes has graduated
approximately 50 MSc and Ph.D. students over her career and established
a Danish Graduate School in Environmental Stress Studies (GESS) based
at Roskilde University. While based in Europe, Dr. Forbes served as
work package leader on two major EU 7th Framework Projects: CREAM (a
Marie Curie Initial Training Network on Mechanistic Effect Models for
Ecological Risk Assessment of Chemicals) and NanoReTox (a multi-
institution research project on The Reactivity and Toxicity of
Engineered Nanoparticles: Risks to the Environment and Human Health).
More recently, she has received funding from the National Institute of
Mathematical and Biological Synthesis (NIMBioS) for multi-partite
initiatives to develop predictive models for the ecological risk
assessment of chemicals. Dr. Forbes has published well over 100
internationally peer-reviewed articles and two books on these topics.
She has served on the Danish Natural Sciences Research Council, the
European Research Council and as ad hoc reviewer for numerous funding
agencies from various countries. She is on the editorial board of
several international journals and provides scientific advice to the
private and public sectors.

7. John Grieco, Ph.D.

    i. Expertise: Epidemiology, ecology, and transmission dynamics of
vector-borne illness.
    ii. Education: Ph.D., Medical Zoology, Uniformed Services
University; MS Medical Entomology, Texas A&M University; BS, Biology,
University of Notre Dame.
    iii. Professional Experience: Dr. John Grieco is a Research
Associate Professor of Medical Entomology and Associate Director of the
Eck Institute of Global Health at the University of Notre Dame in Notre
Dame, Indiana. Dr. Grieco's work is multidisciplinary with a focus on
the biology, ecology and transmission dynamics of vector-borne illness.
He has a long history of working on vector borne disease throughout the
tropics and his research centers on malaria, Japanese Encephalitis,
Dengue, Chagas, and rickettsial pathogens. Dr. Grieco has an extensive
history in the design of novel repellents, irritants and toxicants for
disease vectors. He has developed a number of field and laboratory
assays for identifying and optimizing behavior modifying compounds for
use in the control of mosquito, sandfly, and triatome vectors. Dr.
Grieco serves as an external advisor to the Bill and Melinda Gates
Foundation, the World Health Organization (WHO), the US Centers for
Disease Control and the US Department of Defense in the area of Spatial
Repellents and their advancement to recommendation. Dr. Grieco has co-
authored the WHO guidelines for the evaluation of spatial repellents
and he currently holds two patents for novel repellent compounds.

8. Byron Jones, Ph.D.

    i. Expertise: Toxicogenetics, neurobehavioral, and developmental
toxicology.
    ii. Education: BA, Psychology, Eastern Washington University; MA,
Psychology, University of Arizona; Ph.D. Physiological and Comparative
Psychology, Psychopharmacology, University of Arizona.
    iii. Professional Experience: Dr. Byron Jones is professor of
Genetics, Genomics, and Informatics at the University of Tennessee
Health Sciences Center, Memphis. Dr. Jones received his Ph.D. training
in the Departments of Psychology and Pharmacology and Toxicology at the
University of Arizona. He received postdoctoral training in
neuropharmacology at the University of Arizona and in pharmacogenetics
at the University of Colorado. In 1991, he was a founding member of the
Department of Biobehavioral Health at The Pennsylvania State University
and developed a program in pharmacogenetics and toxicogenetics at that
institution. He has trained 10 Ph.D. and 8 MS students and supervised
numerous undergraduate honors theses at PSU. In 1998-1999, he was
awarded a Poste Orange senior visiting research position at Institute
Fran[ccedil]ois Magendie, Bordeaux, France to study the genetics of
alcohol consumption. In 2000, he was awarded a Harry Dozor visiting

professorship at the Ben Gurion University of the Negev, Beersheba,
Israel. In 2001 and again in 2004, he was awarded invited
professorships at the University of Strasbourg and University of
Bordeaux in France. Together with his colleague, Dr. Pierre
Morm[egrave]de and others, he has helped to organize and deliver 15 1-2
week workshops on neural and behavioral genetics in France, the USA,
Brazil, Russia, and Sweden. He and Dr. Morm[egrave]de co-edited two
volumes of a book on neuro and behavioral genetics. Dr. Jones has
published more than 130 papers in peer-reviewed journals. In 2013, Dr.
Jones was invited to help develop research infrastructure to study the
effects of mercury and pesticide exposure on neurocognitive development
in Ecuador. In 2014, he was awarded two grants from the National
Institutes of Health. One is focused on the role of genetics in the
impact of chronic stress on neuroendocrine adaptation and alcohol
consumption and the other to study the effects of genetics on paraquat
neurotoxicity. In that year, he was recruited to help found a new
department in Genetics, Genomics, and Informatics in the College of
Medicine at UTHSC. He has served on several NIH and NSF review panels.
He is on the editorial board of Frontiers in Genetics and Pharmacology,
Biochemistry and Behavior and is Editor-in-Chief, Nutritional
Neuroscience. His current research interests include: (1) The
toxicogenetics of paraquat and other pesticides; (2) the impact of
chronic stress on neurobehavioral adaptation, including alcohol
consumption; (3) the role of iron status on accumulation of heavy
metals; and (4) iron status and the exposure in pregnant women and in
early childhood development.

9. Paul D. Juarez, Ph.D.

    i. Expertise: Development of methodologies for creating and
analyzing data on the effects of the natural, built, social, and policy
environments on health disparities.
    ii. Education: Ph.D., Public Policy and Social Research, Brandeis
University, Waltham; MEd Psychology, Western Washington University; BA,
Western Washington University.
    iii. Professional Experience: Dr. Paul D. Juarez is Professor,
Preventive Medicine and founding co-director of the Research Center on
Health Disparities, Equity, and the Exposome at the University of
Tennessee Health Science Center. He received his Ph.D. in social policy
from the Heller School, Brandeis University in 1983. Dr. Juarez
currently is serving appointments on the Federal Advisory Committee on
Minority Health for the US Department of Health and Human Services
(2014-2018) and the Community-Level Health Promotion Study Section,
Center for Scientific Review of the NIH (2013-2016). Dr. Juarez
previously served as the Vice Chair, Division of Community Health,
Family & Community Medicine, Meharry Medical College. While at Meharry,
Dr. Juarez was PI for the Meharry Health Disparities Research Center of
Excellence and directed its community engagement core. As PI, Dr.
Juarez led Center activities in developing a systems approach to health
disparities research. In 2011, Dr. Juarez received a grant from the EPA
to increase our understanding of the environmental context of health
disparities. In pursuit of this effort, he led efforts to apply an
exposome framework that considers the cumulative effects of
environmental exposures on human health and development at critical
life stages and from conception to death. He has been at the forefront
nationally in developing a methodology for creating and analyzing data
on the effects of the natural, built, social, and policy environments
on health disparities. To achieve this, he has established a
transdisciplinary team of investigators to conduct focused studies of
the environmental effects on population level health disparities that
apply mathematical, spatial-temporal, statistical and computational
methods, models and analytics. His recent work has focused on analyzing
the effects of the exposome on black white disparities in pre-term
births and lung cancer mortality.

10. Rebecca D. Klaper, Ph.D.

    i. Expertise: Ecological toxicology, chemical environment fate and
effects, examining technologies (including genomics and green chemistry
designs) to minimize environmental impacts from chemical contamination.
    ii. Education: BS, Honors Biology, University of Illinois; MS,
Entomology, University of Georgia; Ph.D., Ecology, University of
Georgia.
    iii. Professional Experience: Dr. Rebecca D. Klaper is a Professor
at the School of Freshwater Sciences, University of Wisconsin-Milwaukee
and the Director of the Great Lakes Genomics Center. Dr. Klaper
received her MS in Entomology in 1995 and her Ph.D. in Ecology in 2000
from the Institute of Ecology University of Georgia examining the
impacts of chemicals on the population dynamics of insects. Dr. Klaper
currently studies the potential impact of emerging contaminants, such
as nanoparticles, pharmaceuticals, personal care products and
pesticides on aquatic life and how we may design these chemicals to be
sustainable and have the least environmental impact. She published some
of the first studies on the impacts of nanomaterials on aquatic
organisms, describing differences in toxicity among nanomaterials,
discussing the possible impacts of surfactants on nanomaterial
toxicology. Dr. Klaper is now one of the lead PI's for the Center for
Sustainable Nanotechnology, a distributed Center of eight universities
to evaluate the mechanisms by which nanomaterials may cause toxicity
and investigate the potential for principles to use in the design
process of these chemicals. Dr. Klaper received a AAAS-Science and
Technology Policy Fellowship where she worked in the National Center
for Environmental Assessment at the US Environmental Protection Agency
evaluating the potential use of genomic technologies in risk
assessment. She currently serves on the Board of Scientific Counselors
for the US Environmental Protection Agency's Chemical Safety for
Sustainability/Human Health Risk Assessment Subcommittee. She has
served as a technical expert to the Alliance for the Great Lakes and
the International Joint Commission regarding the potential impacts of
pharmaceuticals, personal care products and other emerging contaminants
on the Great Lakes. She has also served as an invited scientific expert
to both the US National Nanotechnology Initiative and the International
Organization for Economic Cooperation and Development panel on
nanotechnology where she has testified on the potential impact of
nanoparticles on the environment and the utility of current testing
strategies. She served on the National Academy of Sciences Panel to
Develop a Research Strategy for Environmental, Health, and Safety
Aspects of Engineered Nanomaterials. She is also on the editorial board
of the SETAC journal Environmental Toxicology and Chemistry as well as
the ACS journal Chemical Research in Toxicology. Her current research
focuses on (1) determining the presence of contaminants in freshwater
systems; (2) the impacts of low level chronic exposures of these
chemicals to fish and invertebrates in freshwater systems; (3)
evaluating the ability of contaminant removal technologies to remove
biological impacts of chemicals; (4) methods to quickly assess the
potential impacts of a chemical, including genomic technologies; and
(5) alternative options for minimizing the impacts of emerging
contaminants

including chemical redesign and Green Chemistry, altering use and
distribution, and evaluating prescription levels for pharmaceuticals.
Dr. Klaper's goal is to conduct basic and applied research to inform
policy decisions involving freshwater resources.

11. Polly A. Newcomb, Ph.D.

    i. Expertise: Evaluating environmental exposures, such as metals,
alcohol, tobacco, and medications, and lifestyle or physical factors,
such as physical activity, body mass, genetics, and tumor
characteristics.
    ii. Education: Ph.D., University of Washington, Seattle,
Epidemiology; MPH, Epidemiology, University of Washington; BS,
Molecular Biology, The Evergreen State College.
    iii. Professional Experience: Dr. Polly Newcomb is Head of the
Cancer Prevention Program of the Public Health Sciences Division at the
Fred Hutchinson Cancer Research Center (Fred Hutch), a Professor in the
Department of Epidemiology at the University of Washington's School of
Public Health, and a Senior Scientist at the University of Wisconsin
Comprehensive Cancer Center. She received her doctorate in Epidemiology
at the University of Washington in 1986 and completed her Post-doctoral
Fellowship in the Department of Human Oncology at the University of
Wisconsin in 1987. She has more than 25 years of extramurally funded
research on cancer genetics, etiology, screening, and survival,
demonstrating her broad expertise in the field. Her current research in
relation to health and cancer includes environmental exposures such as
metals, alcohol, tobacco, and medications; lifestyle factors, such as
physical activity and body mass; as well as genetics and tumor
characteristics. Her research has been funded by nearly a score of
foundation and NIH-grants for these studies of colorectal neoplasia,
breast and other cancers, and their precursors. She also participates
in several international consortia. Dr. Newcomb has over 360 peer-
reviewed publications, has served as a mentor for over 40 pre-doctoral,
post-doctoral, and junior investigators and is on the Executive
Committees of four University of Washington/Fred Hutch T32/R25 training
programs. She is active in training new researchers through a National
Cancer Institute ``Established Investigator'' award focused on
colorectal cancer survival. She has served as a member of numerous NIH
Study Sections, a consultant to national and international
organizations, and is an Editor/Associate Editor for top tier journals
such as American Journal of Epidemiology and Cancer, Epidemiology, and
Biomarkers & Prevention. She has recently been awarded mentoring awards
from the University of Washington and the Fred Hutchinson Cancer
Research Center, and is a Fulbright Scholar (2015). She is also the
President of the American Society for Preventive Oncology.

12. Melissa Perry, ScD, MHS

    i. Expertise: Epidemiologic research in public health.
    ii. Education: BA, Psychology, University of Vermont; MHS, Public
Health, The Johns Hopkins University School of Hygiene and Public
Health; ScD, Public Health, The Johns Hopkins University School of
Hygiene and Public Health.
    iii. Professional Experience: Professor Melissa Perry is the
elected President of the American College of Epidemiology. Dr. Melissa
Perry received Master of Health Science and Doctor of Science degrees
from the Johns Hopkins School of Hygiene and Public Health. She has
spent more than two decades conducting epidemiologic research and
educating over 50 graduate students in public health. Prior to coming
to George Washington University in 2010, Dr. Perry spent 13 years on
the Harvard School of Public Health's Department of Environmental
Health faculty. She is currently Chair on the Board of Scientific
Counselors for the National Center for Environmental Health/Agency for
Toxic Substances and Disease Registry (NCEH/ATSDR) of the Centers for
Disease Control and Prevention (CDC). She is also President of the
American College of Epidemiology. She is an associate editor of the
Journal Reproductive Toxicology, and she serves as a standing member of
the National Institute for Occupational Safety and Health research
grant study section. In 2014, Dr. Perry was elected to the prestigious
international Collegium Ramazzini in recognition of her contributions
to advancing occupational and environmental health and her professional
integrity. From 2009-2011, she was a member of the CDC's Scientific
Understanding Work Group, National Conversation on Public Health and
Chemical Exposures, Centers for Disease Control and Prevention. From
2003-2007, she was a co-investigator with the Tropical Pesticides
Research Institute of Arusha, Tanzania, and the University of Cape
Town, South Africa. Her laboratory at the Milken Institute School of
Public Health focuses on reproductive epidemiology and hormone
disruptors, and her group has developed new techniques for high-volume
identification of chromosomal abnormalities in sperm cells. Her
research group was the first to use semi-automated imaging methods to
show how pesticides are associated with sperm abnormalities. In
addition to numerous book chapters and published abstracts, she has
over 110 peer-reviewed publications in areas including DNA damage
linked to pesticides and other chemical exposures, managing hazardous
substances in the workplace, and occupational issues related to
agricultural, meat-packing, and construction work. Current research on
pesticides, biomarkers and hormonal effects in her laboratory focuses
on identifying the mutagenic and hormonal effects of herbicide and
insecticide exposure in vivo. Her interests focus on pre-disease
exposure markers signaled by early mutational damage or hormone
disruption, across the spectrum of pesticide exposure levels. She has
been the principal investigator on research grants from the National
Cancer Institute, the National Institute of Environmental Health
Sciences, and the National Institute for Occupational Safety and
Health.

13. Patricia V. Pietrantonio, Ph.D., MS

    i. Expertise: Applied insect toxicology, insect endocrinology, and
insect biochemistry and physiology.
    ii. Education: Ph.D., Entomology, University of California; MS,
Entomology, Insect Toxicology track, University of California; BS
Agronomy, Plant Breeding Track, University of Buenos Aires.
    iii. Professional Experience: Dr. Patricia Pietrantonio is a
tenured Professor and AgriLife Research Fellow in the Department of
Entomology at Texas A&M University in College Station, TX. She is an
associate member of the interdisciplinary programs in Toxicology and a
member of the Faculty of Neuroscience at the same university. She
received her BS in Agronomy from the University of Buenos Aires in
Argentina, after which she was a permanent technical staff member at
INTA (National Institute of Agriculture and Cattle Technology) in
Castelar, Buenos Aires (1982-1987). She obtained both her MS (1990) and
Ph.D. (1995) in Entomology from the University of California at
Riverside (both under Prof. Sarjeet S. Gill), with emphasis in insect
toxicology, biochemistry, and physiology. As a Ph.D. student, she
received the Henry Comstock Award from the Entomological Society of
America (ESA) for outstanding graduate student achievement. Since 1996,
she has advanced through the ranks at Texas A&M University, receiving
the title of

``AgriLife Research Fellow'' for Outstanding Research Leadership and
Grantsmanship in 2006. She has received funding from the NIH-NIAID
(RO1), NIFA-AFRI, EPA Section 6 and the NSF-IOS, as well as from the
Texas Department of Agriculture and USDA-Southern Region IPM program.
She has served three times as a member on national proposal review
panels for USDA-NIFA Insects and Nematodes (organismal and sub-
organismal panels) and twice for NSF-IOS panels. She reviews research
proposals for European Organizations such as the FWO (Belgium), the ANR
(French Natl. Agency), BBSRC from the UK, the DFG (German Research
Foundation), and national universities. She has served 19 years at
Texas A&M University conducting entomological research ranging from
applied insect toxicology to basic aspects insect endocrinology and
insect biochemistry and physiology (G protein-coupled receptors: GPCRs)
focusing on target validation. In applied toxicology her laboratory
elucidated mechanisms of insecticide resistance to pyrethroids,
neonicotinoids, and organophosphates in various pests such as
mosquitoes, cotton bollworm (H. zea), boll weevil, and whiteflies. Some
of this work was in collaboration with Extension Entomologists. She has
conducted international research on insecticide resistance in Cyprus
funded by the Cyprus Research Promotion Foundation. She has served as
major professor of 7 Ph.D. students and 4 masters students in her
laboratory and served as committee member for 11 graduate students (all
completed). She has served as co-major professor or committee member
for students enrolled in Universities in Mexico and Europe (UK Leuven,
Belgium). Scholarly accomplishments include 49 published peer-reviewed
journal articles, 7 book chapters, and 18 papers in conference
proceedings, as well as published abstracts of 75 invited presentations
(21 international) and 116 volunteered presentations. She teaches
yearly Graduate Courses in Insect Toxicology (ENTO619) and Insect
Physiology (ENTO615). She has served as Subject Editor for
``Environmental Entomology,'' for which she received an Outstanding
Service Award from the ESA. She is currently an associate editorial
member in the Archives of Insect Biochemistry and Physiology and member
of the Editorial board of Open Access Insect Physiology (Ed. Guy
Smagghe). Other honors include the Paul A. Dahm Memorial Lecture in
Insect Toxicology (Iowa State University) and the 2013 College of
Agriculture and Life Sciences Dean's Outstanding Achievement Award for
Faculty Mentoring. She was appointed to the University (TAMU) ADVANCE-
NSF funded project as mentor for minority women. Current research
funded by the NSF-IOS focuses on insect neurobiology and
neuroendocrinology, and research funded by Cotton Incorporated focuses
on Bt toxin and other receptors in the cotton bollworm, H. zea. Other
projects focus on target validation in ticks. Dr. Pietrantonio is also
a member of the tick genome Ix. scapularis expert group.

14. Kenneth Ramos, MD, Ph.D., PharmB

    i. Expertise: Genomics and computational biology, molecular
medicine, environmental health, and toxicology.
    ii. Education: BS, Pharmaceutical Sciences and Chemistry,
University of Puerto Rico, Ph.D., Biochemical Pharmacology, The
University of Texas; MD, University of Louisville Health Sciences
Center.
    iii. Professional Experience: Kenneth Ramos, MD, Ph.D., PharmB,
works across numerous organizational units at the University of Arizona
(UA) to develop precision-health strategies and approaches to health
outcomes and health-care delivery. He provides senior leadership in the
development of personal diagnostics and therapeutics for complex
diseases, including cancer, cardiopulmonary disorders, and diabetes.
Dr. Ramos also is a professor of medicine at the UA College of
Medicine-Tucson in the Department of Medicine, Division of Pulmonary,
Sleep, and Critical Care Medicine, where he directs a highly
competitive and innovative research program in translational and
clinical genetics and genomics. Dr. Ramos' research integrates
approaches ranging from molecular genetics to population-based studies
to understand the genomic basis of human disease. He is regarded as a
leading expert in the study of gene-environment interactions and
directs a competitive research program in translational and clinical
genomics with a focus on genetic and epigenetic determinants of
toxicity and disease, computational biology and molecular signaling.
Dr. Ramos has mentored over 100 doctoral, medical, veterinary medicine,
undergraduate and high school students, many of whom have gone on to
successful careers in academia, medicine, government and industry. He
is committed to initiatives that attract and retain minorities in
science and medicine. Dr. Ramos served as SOT President from 2008-2009,
and is a current member of the Continuing Medical Education Task Force,
Hispanic Organization of Toxicologists Specialty Interest Group, and
the Molecular and Systems Biology Specialty Section. He has been a
member of SOT since 1982.

15. Gary S. Sayler, Ph.D.

    i. Expertise: Microbial biodegradation, molecular microbiology,
bioluminescence sensing and ecotoxicology.
    ii. Education: Ph.D., Bacteriology and Biochemistry, University of
Idaho; BS, Bacteriology, North Dakota State University; AA, Liberal
Arts, Bismarck Junior College.
    iii. Professional Experience: Dr. Sayler is Distinguished
University Professor, and Alvin and Sally Beaman Endowed Professor of
Microbiology and Ecology and Evolutionary Biology at The University of
Tennessee. Dr. Sayler received his Ph.D. in Bacteriology and
Biochemistry, University of Idaho, 1974; BS, Bacteriology, North Dakota
State University, 1971; AA, Bismarck Junior College, Liberal Arts,
1969. He was Postdoctoral researcher in Marine Microbiology at the
University of Maryland (1974-1975). He is the founding Director, Center
for Environmental Biotechnology at the University of Tennessee (1986-
present) and was the first Director of the UT-ORNL Joint Institute for
Biological Sciences (2006-2014). As Director for the Waste Management
Research and Education Institute Tennessee Center of Excellence (1991-
2005) he conducted a consolidation and reorganization to create the
Institute for a Secure and Sustainable Environment serving as interim
director (2005-2006). Specializing in microbial biodegradation,
molecular microbiology, bioluminescence sensing and ecotoxicology, he
has directed the research of over 100 Ph.D. and MS students and
postdocs during his 40 year career, with approximately 400 peer
reviewed publications, 16 patents, and over 500 lectures and seminars
worldwide. He serves on the Sciences Advisory Board for the US Defense
Department, Strategic Environmental Research Defense Program (2011-
present); and was a member of the US Department of Energy, Biological
and Environmental Research Advisory Committee (2008-2013). He was an
Executive member and Chair of the Board of Scientific Counselors for
the EPA Office of Research and Development (2002-2010) and served on
the EPA's Science Advisory Board drinking water committee (2002-2009),
the Water Environment Research Foundation Research Council (1995-2001)
and was Peer Review Chair for the EPA Exploratory Biology Program

(1990-1993). He has served on National Academy/NRC Committees
evaluating the US EPA Laboratory Enterprise (2013-14), DOE NRSB-
Environmental Management Roadmap (2007-2008) Stand-Off Explosives
Detection (2003) and DOE Site Decontamination and Decommissioning
(2002). He is Co-founder China-US Joint Research Center For Ecosystem
and Environmental Change, Beijing, (2006-present) and US State
Department Eco partnership (2010-present) and has held honorary
Professorships at China Agricultural University, Beijing (2012),
Northeast Normal University, Changchun (2012), East China University of
Science and Technology, Shanghai (2008-2011), Institute for Water
Research Distinguished Researcher, Xi'an (2008); and Adjunct
Professorship, Gwanju Institute of Science and Technology, Korea (2005-
2010). Dr. Sayler is an Associate Editor of Environmental Science and
Technology and is an active member in ACS, AAAS, ASM and SETAC. Elected
to AAAS Fellowship in 2012. He received the DOW Foundation Support for
Public Health Environmental Research and Education (SPHERE) Award
(1998-2000); and was elected to the Fellow American Academy for
Microbiology (1995-present). He received the Distinguished Alumni
Award, University of Idaho and the UT Senior Researcher Award from the
College of Arts and Sciences (1995) and received the Procter and Gamble
Prize, American Society for Microbiology (1994). He was designated
Chancellor's Research Scholar, UTK (1988), and received the NIH
Research Career Development Award (NIEHS), (1980-1985).

16. Joseph Shaw, Ph.D.

    i. Expertise: Discovery of molecular toxicological and disease
pathways resulting from complex environmental exposures including
techniques in new high-throughput molecular techniques and evolutionary
theory, statistical analysis, and bioinformatics.
    ii. Education: Ph.D., University of Kentucky; BS, Virginia
Polytechnic Institute and State University.
    iii. Professional Experience: Dr. Joseph R. Shaw is an Associate
Professor in the School of Public and Environmental Affairs at Indiana
University and holds adjunct appointments in their School of Public
Health and Center for Genomics and Bioinformatics. He also holds a
partial appointment as a Senior Lecturer of Environmental Genomics in
the School of Biosciences at the University of Birmingham, UK. Dr. Shaw
earned his doctoral degree in environmental toxicology from the
Graduate Center for Toxicology at the University of Kentucky in 2001.
He then moved to Dartmouth College where he received an NIEHS post-
doctoral fellowship to apply emerging Omics technologies to
characterize mechanisms of toxicant actions. He joined the faculty of
the School of Public and Environmental Affairs at Indiana University,
Bloomington in 2007. Dr. Shaw was named an Outstanding New
Environmental Scientist (ONES) by the NIEHS in 2010, and recognized as
an exceptional talent in the environmental sciences by the Royal
Society, UK in 2013 for his work investigating toxicant exposure,
genome structure, and toxic effects on individuals and populations.
Contributing to these efforts he is a founding member of the Daphnia
and Fundulus Genomics Consortia where he helps lead over 600 scientists
around the world working to develop new models for environmental
genomics. He also helped establish the Consortium for Environmental
Omics and Toxicology that seeks to apply twenty-first century
technologies to predictive toxicology. Dr. Shaw has trained over 150
students in environmental genomics through the Mount Desert Island Bio
Lab Workshop in environmental genomics that he co-developed in 2011.
The workshop is now held annually in the US and UK. Dr. Shaw's research
program has received over $6.4M in research funding from NIH, NSF, and
DOD since 2002, producing over 38 publications in the area of
environmental genomics and toxicology. He has served on the editorial
board and in 2013, was promoted to editor for the journal
``Environmental Toxicology and Chemistry.'' His research group seeks to
discover critical, specific, and causative molecular toxicological and
disease pathways resulting from complex environmental exposures. His
work embraces new high-throughput molecular techniques and couples
these with evolutionary theory, statistical analysis, and
bioinformatics to integrate toxic-response across levels of biological
organization. Current research in his laboratory focuses on (i)
associating variation in genome structure with disease and toxicant
response within and between populations; (ii) identifying the
mechanisms of actions of chemical stress, especially metals, and (iii)
elucidating the genetic and epigenetic underpinnings of mutations and
establishing their role in evolved tolerance.

17. Sonya K. Sobrian, Ph.D.

    i. Expertise: Behavioral, immunological and neurotoxicological
consequences of prenatal and neonatal drug administration and drug and
environmental stress.
    ii. Education: Ph.D. Physiological Psychology, from Carleton
University; BA and MA (Experimental) in Psychology from St. John's
University; MA equivalent in Pharmacology from Ottawa University.
    iii. Professional Experience: Dr. Sonya K. Sobrian is an Associate
Professor of Pharmacology at the Howard University College of Medicine,
Director of the Developmental Neurobehavioral Pharmacology Laboratory,
and Immediate Past Chair of the University's IACUC. Dr. Sobrian
received her doctorate in Physiological Psychology from Carleton
University, Ottawa Canada, and served a postdoctoral fellowship at
Princeton University in Developmental Neurobiology; she also added
pharmacology and immunology to her graduate (MA, Neuropharmacology:
Ottawa University) and post graduate (Fulbright Fellow: Immunology
Research Center, Belgrade, Yugoslavia) training. During her tenure at
the College of Medicine, Dr. Sobrian successfully mentored medical,
graduate, and undergraduate students. She has served as President of
the Neurobehavioral Teratology Society, is currently on the Editorial
Advisory Board of the journal, ``Neurotoxicology and Teratology'', and
is Guest Editor of a special issue of the journal on ``Developmental
Cannabinoid Exposure: New Perspectives on Mechanisms, Outcomes, and
Implications for Public Health.'' Dr. Sobrian is currently on the Board
of Scientific Counselors for the Department of Health & Human Services
National Toxicology Program. She also served as a member of the
Scientific Advisory Panel for the US EPA Office of Chemical Safety and
Pollution Prevention, and previously served on the EPA Toxic Substance
Control Act Advisory Committee. As a visiting scientist at the National
Center for Toxicological Research, Dr. Sobrian was instrumental in
establishing a prenatal model of cocaine toxicity. She served on the
ILSI Risk Science Institute's Expert Panel on the evaluation and
interpretation of neurodevelopmental endpoints for human risk. Dr.
Sobrian served as Director of the Behavioral Neuroscience Program at
the National Science Foundation, where she directed and managed funding
of research on the neural mechanisms underlying behavior and learning.
In addition, she has served as Chair of the Board of Trustees of AAALAC
International, as well as Chair of the Board of Directors of the
National Capital Area Chapter of the Fulbright Association. During her
tenure as an

AAAS Congressional Science and Technology Fellow, her scientific
expertise was utilized to inform public policy on Fetal Alcohol
Syndrome, aging, and NIH research funding. The major focus of Dr.
Sobrian's research involves the behavioral, immunological, and
neurotoxicological consequences of prenatal and neonatal drug
administration and drug and environmental stress-induced alterations in
behavioral and immunological development. She has a longstanding
interest in sex differences, and her lab was the first to show that
prenatal environmental and psychological stress differentially altered
immune parameters in rat male and female offspring, research that she
continued as a Fulbright Scholar at the Immunological Research
Institute in Belgrade, Yugoslavia. Her current research involves the
life-span consequences of prenatal exposure to cocaine and nicotine,
alone and in combination, with an emphasis on drug addiction in the
aging organism. In developing animal models for neuropsychiatric
diseases, Dr. Sobrian is currently exploring the role of prenatal
environmental noise stress [PENS] in the etiology of autism and
depression. For her work in establishing an environmentally-mediated
neurodevelopmental animal model of depression, Dr. Sobrian was
designated a L. Vernon Maddox NARSAD investigator.

18. Kristina Thayer, Ph.D.

    i. Expertise: Understanding the role of environmental exposures in
diabetes and obesity, evaluating the predictive utility of high
throughput screening data, and methods of exposure assessment.
    ii. Education: BS, Psychology, Pennsylvania State University;
Ph.D., Biological Sciences, University of Missouri.
    iii. Professional Experience: Kristina Thayer, Ph.D. is Deputy
Director of Analysis at the National Toxicology Program (NTP) and
Director of the NTP Office of Health Assessment and Translation (OHAT)
at the National Institute for Environmental Health Sciences (NIEHS)
located on the campus of the National Institute for Environmental
Health Sciences (NIEHS). OHAT conducts evaluations to assess the
evidence that environmental chemicals, physical substances, or mixtures
(collectively referred to as ``substances'') may cause adverse health
effects and provides opinions on whether these substances may be of
concern given what is known about current human exposure levels. As
Deputy Director of Analysis, she oversees OHAT and the NTP Office of
the Report on Carcinogens. Before becoming director of OHAT, she held
positions in the NTP Office of Liaison, Policy, and Review, the NIEHS
Office of Risk Assessment Research and the NTP Center for the
Evaluation of Risks to Human Reproduction (CERHR). Prior to joining the
NTP/NIEHS, she was a senior scientist at the World Wildlife Fund and
then at the Environmental Working Group. In addition to overseeing the
development of OHAT and ORoC monographs, she has research interests in
the areas of understanding the role of environmental exposures in
diabetes and obesity, evaluating the predictive utility of high
throughput screening data, and methods of exposure assessment. She is
considered an expert on the application of systematic review methods to
environmental health topics.

    Authority:  7 U.S.C. 136 et. seq.; 21 U.S.C. 301 et seq.

    Dated: August 5, 2015.
David Dix,
Director, Office of Science Coordination and Policy.
[FR Doc. 2015-19828 Filed 8-11-15; 8:45 am]
 BILLING CODE 6560-50-P